Anti-FRG1 antibody (184-234 aa) (STJ197678)

SKU:
STJ197678

Current Stock:
Host: Rabbit
Applications: WB
Reactivity: Human/Mouse
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: Rabbit polyclonal antibody anti-Protein FRG1 (184-234 aa) is suitable for use in Western Blot research applications.
Clonality: Polyclonal
Conjugation: Unconjugated
Isotype: IgG
Formulation: Liquid in PBS containing 50% Glycerol, 0.5% BSA and 0.02% Sodium Azide.
Purification: The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Concentration: 1 mg/mL
Dilution Range: WB 1:1000-2000
Storage Instruction: Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles.
Gene Symbol: FRG1
Gene ID: 2483
Uniprot ID: FRG1_HUMAN
Immunogen Region: 184-234 aa
Specificity: This antibody detects endogenous levels of human FRG1
Immunogen: Synthesized peptide derived from the human FRG1 at the amino acid range 184-234
Function Binds to mRNA in a sequence-independent manner. May play a role in regulation of pre-mRNA splicing or in the assembly of rRNA into ribosomal subunits. May be involved in mRNA transport. May be involved in epigenetic regulation of muscle differentiation through regulation of activity of the histone-lysine N-methyltransferase KMT5B.
Protein Name Protein Frg1
Fshd Region Gene 1 Protein
Cellular Localisation Nucleus
Cajal Body
Nucleolus
Cytoplasm
Myofibril
Sarcomere
Z Line
Localization Changes During Myogenesis From Mainly Cytoplasmic In Undifferentiated Myoblasts
To Strongly Nucleolar In Early Myotubes And Back To Cytoplasmic 5 Days Post-Differentiation
Localized At The Z-Line In The Sarcomere Of Matured Myotubes 8 Days Post-Differentiation
Alternative Antibody Names Anti-Protein Frg1 antibody
Anti-Fshd Region Gene 1 Protein antibody
Anti-FRG1 antibody

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance